| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.27M | 20.50M | 22.71M | 21.65M | 14.75M | 18.13M |
| Gross Profit | 7.74M | 10.01M | 10.40M | 11.10M | 8.92M | 10.50M |
| EBITDA | -217.00K | 92.00K | -3.76M | 2.52M | 2.60M | 2.30M |
| Net Income | -2.18M | -1.83M | -5.90M | -7.00K | 451.00K | 240.00K |
Balance Sheet | ||||||
| Total Assets | 36.37M | 37.95M | 30.45M | 39.12M | 27.56M | 27.33M |
| Cash, Cash Equivalents and Short-Term Investments | 8.12M | 8.74M | 1.94M | 4.19M | 4.13M | 3.47M |
| Total Debt | 5.06M | 5.14M | 5.34M | 5.51M | 1.14M | 1.59M |
| Total Liabilities | 13.52M | 14.21M | 15.68M | 17.69M | 6.30M | 6.71M |
| Stockholders Equity | 22.85M | 23.73M | 14.77M | 21.43M | 21.26M | 20.61M |
Cash Flow | ||||||
| Free Cash Flow | -716.00K | -1.37M | -369.00K | 2.30M | 1.42M | 2.13M |
| Operating Cash Flow | -555.00K | -620.00K | 190.00K | 2.72M | 2.31M | 2.70M |
| Investing Cash Flow | -850.00K | -689.00K | -559.00K | -5.80M | -891.00K | -1.55M |
| Financing Cash Flow | -403.00K | 8.11M | -1.87M | 3.14M | -758.00K | -713.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £677.44M | 8.86 | 60.89% | 5.54% | 7.83% | 2.36% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | £61.46M | 9.55 | -3.99% | ― | -5.43% | -292.31% | |
60 Neutral | £113.44M | -23.06 | 2.17% | ― | 26.09% | 32.43% | |
45 Neutral | £11.30M | -3.01 | -9.36% | ― | -7.45% | 78.23% | |
43 Neutral | £13.29M | -0.96 | -99.34% | 23.79% | 25.44% | -1877.56% | |
42 Neutral | £1.96M | -4.20 | ― | ― | ― | ― |